Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

We previously identified an extracellular matrix (ECM) gene expression pattern in breast cancer (BC), called ECM3, characterized by a high expression of genes encoding structural ECM proteins. Since ECM is reportedly implicated in response to therapy of BCs, the aim of this work is to investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rybinska, Ilona, Sandri, Marco, Bianchi, Francesca, Orlandi, Rosaria, De Cecco, Loris, Gasparini, Patrizia, Campiglio, Manuela, Paolini, Biagio, Sfondrini, Lucia, Tagliabue, Elda, Triulzi, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072535/
https://www.ncbi.nlm.nih.gov/pubmed/32069815
http://dx.doi.org/10.3390/cells9020434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072535/
https://www.ncbi.nlm.nih.gov/pubmed/32069815
http://dx.doi.org/10.3390/cells9020434

Ejemplares similares